Edgar Zitron

2.2k total citations
77 papers, 1.6k citations indexed

About

Edgar Zitron is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Edgar Zitron has authored 77 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Cardiology and Cardiovascular Medicine, 49 papers in Molecular Biology and 20 papers in Cellular and Molecular Neuroscience. Recurrent topics in Edgar Zitron's work include Cardiac electrophysiology and arrhythmias (55 papers), Ion channel regulation and function (45 papers) and Cardiac pacing and defibrillation studies (20 papers). Edgar Zitron is often cited by papers focused on Cardiac electrophysiology and arrhythmias (55 papers), Ion channel regulation and function (45 papers) and Cardiac pacing and defibrillation studies (20 papers). Edgar Zitron collaborates with scholars based in Germany, United States and Netherlands. Edgar Zitron's co-authors include Hugo A. Katus, Christoph A. Karle, Dierk Thomas, Eberhard P. Scholz, Sven Kathöfer, Claudia Kiesecker, Johann Kiehn, Ramona Bloehs, Wolfgang Schoels and D. Scherer and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Edgar Zitron

76 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edgar Zitron Germany	26	1.1k	934	288	102	79	77	1.6k
Christoph A. Karle Germany	28	1.5k 1.4×	1.4k 1.5×	399 1.4×	68 0.7×	36 0.5×	73	2.1k
Jean‐Sébastien Rougier Switzerland	24	1.2k 1.1×	1.4k 1.5×	372 1.3×	72 0.7×	37 0.5×	59	1.9k
Wolfgang Schoels Germany	27	1.6k 1.5×	662 0.7×	178 0.6×	97 1.0×	38 0.5×	87	1.9k
Anton Lukas Canada	21	1.5k 1.4×	1.1k 1.2×	252 0.9×	80 0.8×	32 0.4×	48	2.1k
Lin Wu China	19	772 0.7×	636 0.7×	173 0.6×	61 0.6×	20 0.3×	44	1.1k
Arvinder K. Dhalla United States	24	960 0.9×	845 0.9×	155 0.5×	193 1.9×	41 0.5×	53	2.0k
Ali A. Sovari United States	17	923 0.9×	615 0.7×	109 0.4×	58 0.6×	20 0.3×	34	1.3k
Elena S. Trepakova United States	14	372 0.3×	779 0.8×	300 1.0×	58 0.6×	20 0.3×	17	1.1k
Wolfgang Klaus Germany	20	493 0.5×	494 0.5×	123 0.4×	70 0.7×	25 0.3×	47	1.2k
Anthony Yiu‐Ho Woo China	21	284 0.3×	793 0.8×	233 0.8×	52 0.5×	11 0.1×	38	1.2k

Countries citing papers authored by Edgar Zitron

Since Specialization

Citations

This map shows the geographic impact of Edgar Zitron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edgar Zitron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edgar Zitron more than expected).

Fields of papers citing papers by Edgar Zitron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edgar Zitron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edgar Zitron. The network helps show where Edgar Zitron may publish in the future.

Co-authorship network of co-authors of Edgar Zitron

This figure shows the co-authorship network connecting the top 25 collaborators of Edgar Zitron. A scholar is included among the top collaborators of Edgar Zitron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edgar Zitron. Edgar Zitron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rahm, Ann‐Kathrin, D. Scherer, Claudia Seyler, et al.. (2022). Verapamil inhibits Kir2.3 channels by binding to the pore and interfering with PIP2 binding. Naunyn-Schmiedeberg s Archives of Pharmacology. 396(4). 659–667. 1 indexed citations

Scholz, Eberhard P., Patrick Lugenbiel, Patrick A. Schweizer, et al.. (2018). Novel approach to discriminate left bundle branch block from nonspecific intraventricular conduction delay using pacing-induced functional left bundle branch block. Journal of Interventional Cardiac Electrophysiology. 53(3). 347–355. 2 indexed citations

Scherer, D., Benedikt Schworm, Claudia Seyler, et al.. (2017). Inhibition of inwardly rectifying Kir2.x channels by the novel anti-cancer agent gambogic acid depends on both pore block and PIP2 interference. Naunyn-Schmiedeberg s Archives of Pharmacology. 390(7). 701–710. 10 indexed citations

Scherer, D., Claudia Seyler, Eberhard Scholz, et al.. (2017). Dual Mechanism for Inhibition of Inwardly Rectifying Kir2.x Channels by Quinidine Involving Direct Pore Block and PIP2-interference. Journal of Pharmacology and Experimental Therapeutics. 361(2). 209–218. 7 indexed citations

Zhang, Wei, Marc Freichel, F. van der Hoeven, et al.. (2016). Novel Endothelial Cell-Specific AQP1 Knockout Mice Confirm the Crucial Role of Endothelial AQP1 in Ultrafiltration during Peritoneal Dialysis. PLoS ONE. 11(1). e0145513–e0145513. 18 indexed citations

Seyler, Claudia, D. Scherer, Eberhard Scholz, et al.. (2014). Class III antiarrhythmic drug dronedarone inhibits cardiac inwardly rectifying Kir2.1 channels through binding at residue E224. Naunyn-Schmiedeberg s Archives of Pharmacology. 387(12). 1153–1161. 6 indexed citations

Sedaghat‐Hamedani, Farbod, Edgar Zitron, Elham Kayvanpour, et al.. (2014). Post cardiac injury syndrome after initially uncomplicated CRT-D implantation: a case report and a systematic review. Clinical Research in Cardiology. 103(10). 781–789. 20 indexed citations

Zylla, Maura M., Alexander Heß, Derliz Mereles, et al.. (2014). Prevalence of Intracardiac Thrombi Under Phenprocoumon, Direct Oral Anticoagulants (Dabigatran and Rivaroxaban), and Bridging Therapy in Patients With Atrial Fibrillation and Flutter. The American Journal of Cardiology. 115(5). 635–640. 30 indexed citations

Scholz, Eberhard P., Paola Carrillo-Bustamante, Mathias Wilhelms, et al.. (2013). Rotor Termination Is Critically Dependent on Kinetic Properties of IKur Inhibitors in an In Silico Model of Chronic Atrial Fibrillation. PLoS ONE. 8(12). e83179–e83179. 18 indexed citations

10.

Korkmaz, Sevil, Edgar Zitron, Claudia Seyler, et al.. (2013). Provocation of an Autoimmune Response to Cardiac Voltage-Gated Sodium Channel NaV1.5 Induces Cardiac Conduction Defects in Rats. Journal of the American College of Cardiology. 62(4). 340–349. 26 indexed citations

11.

Zitron, Edgar, Claudia Seyler, D. Scherer, et al.. (2013). Inhibition of cardiac Kv1.5 and Kv4.3 potassium channels by the class Ia anti-arrhythmic ajmaline: mode of action. Naunyn-Schmiedeberg s Archives of Pharmacology. 386(11). 991–999. 18 indexed citations

12.

Seyler, Claudia, D. Scherer, Eberhard P. Scholz, et al.. (2012). Inhibition of cardiac Kir2.1–2.3 channels by beta3 adrenoreceptor antagonist SR 59230A. Biochemical and Biophysical Research Communications. 424(2). 315–320. 5 indexed citations

13.

Scholz, Eberhard P., Edgar Zitron, Hugo A. Katus, & Christoph A. Karle. (2010). Cardiovascular Ion Channels as a Molecular Target of Flavonoids. Cardiovascular Therapeutics. 28(4). e46–52. 38 indexed citations

14.

Gierten, Jakob, Eckhard Ficker, Ramona Bloehs, et al.. (2009). Inhibition of hK2P3.1 (TASK-1) Potassium Channels by the Tyrosine Kinase Inhibitor Genistein. Biophysical Journal. 96(3). 563a–563a. 1 indexed citations

15.

Gierten, Jakob, Eckhard Ficker, Ramona Bloehs, et al.. (2008). Regulation of two‐pore‐domain (K_2P) potassium leak channels by the tyrosine kinase inhibitor genistein. British Journal of Pharmacology. 154(8). 1680–1690. 56 indexed citations

16.

Scholz, Eberhard P., Franziska M. Konrad, Daniel L. Weiß, et al.. (2007). Anticholinergic antiparkinson drug orphenadrine inhibits HERG channels: block attenuation by mutations of the pore residues Y652 or F656. Naunyn-Schmiedeberg s Archives of Pharmacology. 376(4). 275–284. 13 indexed citations

17.

Kiesecker, Claudia, Edgar Zitron, D. Scherer, et al.. (2005). Regulation of cardiac inwardly rectifying potassium current IK1 and Kir2.x channels by endothelin-1. Journal of Molecular Medicine. 84(1). 46–56. 24 indexed citations

18.

Zitron, Edgar. (2004). Human cardiac inwardly rectifying current IKir2.2 is upregulated by activation of protein kinase A. Cardiovascular Research. 63(3). 520–527. 37 indexed citations

19.

Zitron, Edgar, Claudia Kiesecker, Eberhard P. Scholz, et al.. (2004). Inhibition of cardiac HERG potassium channels by the atypical antidepressant trazodone. Naunyn-Schmiedeberg s Archives of Pharmacology. 370(2). 146–56. 40 indexed citations

20.

Thomas, Dierk, Sven Kathöfer, Wei Zhang, et al.. (2003). Acute effects of dronedarone on both components of the cardiac delayed rectifier K⁺ current, HERG and KvLQT1/minK potassium channels. British Journal of Pharmacology. 140(5). 996–1002. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact